Navigation Links
Switzerland Posts Biotech Gains in 2009
Date:5/26/2010

NEW YORK, May 26 /PRNewswire/ -- Despite a less than favorable global economic environment the Swiss biotechnology industry performed rather well in 2009, reports Mario Brossi, North American senior advisor for Switzerland Trade and Investment Promotion.  According to the Swiss Biotech Report 2010 employment in the sector grew 6% to 19,071 while turnover reached CHF 9.3 billion*, a 7% increase over the prior year.

"The report notes that while the financing environment was challenging, Swiss companies were able to raise CHF 370 million in new capital, led by NovImmune's CHF 60 million in venture capital," Mr. Brossi said.  "BioMedInvest II raised CHF 100 million in new capital and Index Ventures EUR 350 million for early stage investment."

In other activity mondoBiotech floated its shares on the SWX Swiss Exchange, Evolva became public through a reverse merger with Arpida, and ESBATech in a transaction worth up to CHF 600 million was acquired by eye care leader Alcon.

"A measure of a country's ranking in a particular field is the number of patents filed per million of population," Mr. Brossi said.  "The World Patent Index reports that for Switzerland the number of biotech patents registered under this criterion is about 250.  This compares favorably with the U.S. (70), Japan (65), Germany (45), and Great Britain (40).  Much of the country's success in biotech is due to strong Federal support, its network of excellent research institutions and research-oriented industrial players."

According to the Swiss Biotech Report 2010 as of 2009 there were 327 biotech firms in the country, of which 65 are classified as suppliers to the industry.

Switzerland at BIO 2010

At the recently concluded BIO 2010 International Convention in Chicago, Swiss biotech was represented by 18 companies in the Swiss Pavilion and 9 pavilion partners including cantonal and regional economic development agencies, Swiss biotech clusters, the SIX Swiss Exchange, and the country's innovation promotion agency CTI.  Swiss presentations during the technical sessions covered monoclonal antibodies and white (industrial) biotechnology.  The Swiss Delegation was the 10th largest country delegation at BIO.

Further information at www.swissbiotechreport.ch

*1 Swiss Franc (CHF) = ~U.S. $0.86


'/>"/>
SOURCE Switzerland Trade and Investment Promotion
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
2. Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
3. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
4. 16th International Process Development Conference to be Held June 14-17, 2009 in Arosa, Switzerland
5. Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida
6. Pharmaxis Aridol Approved for Sale in Switzerland
7. 220 Companies Place Switzerland First in Biotech Density Per Capita
8. First CyberKnife System Sold in Switzerland
9. Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
10. Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
11. OpenQ Posts a 200% Revenue Growth in the First Half of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):